Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that colonizes the human stomach. It is a true “survival expert,” capable of thriving in the stomach’s highly acidic environment. Since Barry Marshall and Robin Warren discovered its link to gastritis and peptic ulcers in 1982, its connection to stomach cancer has been progressively revealed. Today, the World Health Organization (WHO) classifies H. pylori as a Group 1 carcinogen.
The Global Scope of H. pylori Infection
The global infection rate of H. pylori remains persistently high. Statistics show that approximately 50% of the world’s population is infected, with even higher rates in developing countries. In China, the infection rate ranges from 40% to 60%. With such a massive infected population, a crucial question arises: Can Helicobacter pylori be completely cured?
Common Symptoms and the Challenge of Antibiotic Resistance
Roughly 70% of H. pylori-positive individuals are asymptomatic. However, some may experience:
- Dull upper abdominal pain or burning sensations
- Post-meal bloating and frequent burping
- Stubborn bad breath (halitosis)
- Nausea and a loss of appetite
Through standardized antibacterial treatment, H. pylori can be eradicated, but it requires more than just taking pills for a few days. For decades, the standard treatment was a triple therapy consisting of a Proton Pump Inhibitor (PPI), clarithromycin, and amoxicillin. Unfortunately, antibiotic resistance has turned this once-effective regimen into a stumbling block for successful eradication.
A massive 2025 study published in the journal Gut, covering 31 countries, revealed a sharp global increase in antibiotic resistance. Among 24 surveyed countries, clarithromycin resistance exceeded 15%; in 18 countries, levofloxacin resistance surpassed 15%. In regions like East Asia and Southern Europe, clarithromycin resistance has soared past 20% to 30%.
Clinical data from China shows resistance rates for clarithromycin and levofloxacin hovering between 20% and 40%, while metronidazole resistance is staggeringly high at 60% to 90%. Consequently, the eradication rate of the traditional “triple therapy” has plummeted, dropping below 80% in some areas due to this severe drug resistance.
New Breakthroughs in H. pylori Treatment
Facing the resistance dilemma, modern medicine has adapted with more effective protocols:
1. Bismuth Quadruple Therapy The 2022 Chinese Guidelines for the Treatment of Helicobacter pylori Infection clearly state that Bismuth Quadruple Therapy should be the first-line preferred regimen. This fixed 14-day protocol consists of a PPI, bismuth, and two antibiotics. Compared to the old regimen, it boosts the eradication rate by 10% to 15%.
2. Rifasutenizol: A Powerful New Option Notably, a newly developed Chinese drug, Rifasutenizol, offers a major breakthrough. Research published in The Lancet Infectious Diseases in 2024 demonstrated that a novel triple therapy combining rifasutenizol, rabeprazole, and amoxicillin achieved an impressive 92.0% eradication rate. Even in multi-drug-resistant populations, it maintained an 89.9% success rate, with significantly fewer side effects than traditional quadruple therapies. This is a game-changer for patients who cannot tolerate quadruple therapy or have experienced repeated treatment failures.
Who Needs Immediate Treatment?
Not everyone who tests positive for H. pylori requires immediate medication. However, eradication is strictly mandatory for patients with:
- Peptic ulcers (active or scarred)
- Gastric MALT lymphoma
- Post-gastric cancer surgery
- High-grade gastric intraepithelial neoplasia
- Chronic gastritis with atrophy or intestinal metaplasia
Proactive treatment is highly beneficial for:
- First-degree relatives of stomach cancer patients
- Long-term users of aspirin or NSAIDs
- Patients with unexplained iron-deficiency anemia or idiopathic thrombocytopenic purpura (ITP)
- Individuals with chronic gastritis and dyspepsia symptoms
Conversely, for asymptomatic, low-risk individuals under 40 with no family history or mucosal lesions, consensus guidelines recommend a personalized assessment rather than blind medication. The potential side effects of antibiotics, such as gut microbiota disruption, may outweigh the benefits.
Post-Treatment Testing and Family Prevention
After completing the eradication therapy, patients must wait at least 4 weeks off medication before taking a Carbon-13 (C13) or Carbon-14 (C14) Urea Breath Test to confirm whether the bacteria have been cleared. With an accuracy rate exceeding 95%, breath tests are the preferred clinical diagnostic tool. While H. pylori can be cured, reinfection is possible, though the rate is relatively low at 1% to 3%.
Family prevention is critical. H. pylori spreads primarily through oral-oral and fecal-oral routes. Sharing meals, toothbrushes, and mouth-to-mouth feeding can lead to cross-infection. If one family member tests positive, whole-family screening is recommended. Implement the use of serving chopsticks/spoons, regularly disinfect tableware, and strictly avoid mouth-to-mouth feeding with children.
Herbal Support and Natural Remedies for Stomach Health
For those seeking gentle, herbal-based assistance for stomach recovery, products like Jiyitang Wei Ling Bao and You Men Bao offer viable alternative support.
- Wei Ling Bao: Extracted from botanical essences like Reishi mushroom (Lingzhi), Ophiopogon (Maidong), and Poria cocos (Fuling), it helps repair the gastric mucosa, neutralize stomach acid, and improve gastric motility.
- You Men Bao: Featuring an antibiotic-free herbal compound formula, it regulates the stomach’s microecology using natural ingredients. This antibiotic-free approach helps combat H. pylori and is highly suitable for long-term maintenance and auxiliary care for patients dealing with recurrent infections.
Conclusion
Although Helicobacter pylori infection is widespread, it is highly treatable. With the guidance of scientifically standardized treatment plans and new medical advancements, we are fully capable of eliminating this stubborn bacterium from the stomach and reclaiming our digestive health.